Key result
AD8232-based amplifier circuit conditions biopotential signals with up to ~15,200-fold gain at ECG frequencies.
Why the study?
Accurate ECG signal acquisition is challenged by low signal amplitudes and ambient electrical interference, necessitating improved signal conditioning circuits.
The AD8232-based circuit effectively amplifies low-frequency biopotential signals corresponding to the physiological ECG spectrum, providing a low-cost, portable solution for wearable cardiac monitoring.
Prototype needs clinical validation before ECG use; leaves open real-world reliability and integration testing.
Cardiovascular activity monitoring relies heavily on accurate Electrocardiogram (ECG) signal acquisition, which is often challenged by low signal amplitudes (1 mV) and ambient electrical interference. This study presents the design, hardware implementation, and performance characterization of a compact, cost-effective biopotential signal conditioning circuit based on the AD8232 front-end IC. Utilizing a Research and Development (R&D) framework, the proposed system integrates an instrumentation amplifier, active High-Pass (HPF) and Low-Pass (LPF) filters, and Right Leg Drive (RLD) circuitry onto a single module to optimize Common Mode Rejection Ratio (CMRR) and reduce PCB footprint. Experimental evaluations were conducted across varying input signal periods (4.00 ms to 80.0 ms) and external resistor configurations using a digital storage oscilloscope. Results demonstrate that lower input frequencies yield significantly higher amplification, achieving peak-to-peak output voltages (Vpp) of 14.0 V and 15.2 V with total gains of 14.000x and 15.200x at input periods of 40.0 ms (25 Hz) and 80.0 ms (12.5 Hz), respectively. This frequency-dependent gain scaling matches the dominant low-frequency spectrum of physiological ECG signals (0.05 Hz to 150 Hz). However, certain high-resistance setups (e.g., 986 kΩ) induced signal saturation, underscoring the necessity of precise component selection. Overall, the prototype provides a reliable, adaptable, and low-cost solution for wearable cardiac monitoring systems.
No takes yet. Share an insight, caveat, or question.
Yanti et al. (2026) studied Cardiac activity monitoring (Electrocardiogram). AD8232-based ECG signal conditioning circuit was evaluated on Circuit gain and peak-to-peak output voltage (Vpp) across varying input signal periods. The AD8232-based heartbeat signal amplifier circuit effectively conditioned biopotential signals, achieving up to 15,200x gain and 15.2 V peak-to-peak output at low frequencies matching human ECGs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: